Kerala Ayurveda — 360° view

Kerala Ayurveda, a company in the Pharmaceuticals industry, reported revenue of ₹36 crore and a net loss of ₹6.10 crore for the September 2026 quarter.

Kerala Ayurveda (BSE: KERALAYUR) closed at ₹136.45 on 20 Nov 2026, down 64.4% over the past year. Its market capitalisation is ₹186 crore.

Share price
₹136.45 (20 Nov 2026)
Market cap
₹186 Cr (20 Nov 2026)
Revenue
₹36 Cr (September 2026 quarter)
Net profit
₹-6 Cr (September 2026 quarter)
ROCE
-9.77% (FY26)
ROE
-161% (FY26)
Book value
₹1.29 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹391.95 / ₹130.00 (20 Nov 2026)
1-year return
-64.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: KERALAYUR

Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.